ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,899Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 783

$1.12M Total Retail Price of All Prescriptions

Rank: 36 out of 783

599 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 599 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

19% of this provider’s 599 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 16,355 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 890 729 1 1
FUROSEMIDE 702 639 2 7
HYDROCODONE-ACETAMINOPHEN 588 375 S3 3 2
WARFARIN SODIUM 504 497 4 10
LISINOPRIL 478 392 5 4
POTASSIUM CHLORIDE 437 349 6 16
SIMVASTATIN 427 361 7 3
OMEPRAZOLE 420 325 8 6
NAMENDA 388 381 9 32
TRIAMTERENE-HCTZ 330 305 10 42
AMLODIPINE BESYLATE 316 257 11 5
PRAVASTATIN SODIUM 300 224 12 14
TRAMADOL HCL 298 265 13 20
DONEPEZIL HCL 298 285 13 24
SERTRALINE HCL 291 252 15 22
METOPROLOL TARTRATE 283 270 16 9
LOVASTATIN 273 255 17 58
CITALOPRAM HBR 270 225 18 19
MELOXICAM 245 203 19 37
RISPERIDONE 221 178 20 67
LANTUS 205 177 21 38
ALENDRONATE SODIUM 197 178 22 25
GABAPENTIN 197 146 22 15
METFORMIN HCL 184 145 24 8
ATORVASTATIN CALCIUM 173 147 25 11
ALLOPURINOL 162 157 26 31
ATENOLOL 153 132 27 17
CYMBALTA 147 77 28 35
SULFAMETHOXAZOLE-TRIMETHOPRIM 147 128 28 95
TAMSULOSIN HCL 146 144 30 26
CEPHALEXIN 146 133 30 70
METOPROLOL SUCCINATE 139 112 32 13
HYDRALAZINE HCL 134 100 33 78
CIPROFLOXACIN HCL 131 117 34 62
FLUOXETINE HCL 125 86 35 45
MIRTAZAPINE 125 112 35 52
FOSINOPRIL SODIUM 124 113 37 258
ESCITALOPRAM OXALATE 113 81 38 54
CARVEDILOL 111 86 39 21
LEVOFLOXACIN 109 93 40 75
HYDROCHLOROTHIAZIDE 109 79 40 12
NYSTATIN 108 95 42 106
ISOSORBIDE MONONITRATE ER 108 106 42 40
LOSARTAN POTASSIUM 99 92 44 18
DIGOXIN 99 89 44 61
RIVASTIGMINE 95 95 46 249
AZITHROMYCIN 93 79 47 41
ENALAPRIL MALEATE 93 85 47 68
QUETIAPINE FUMARATE 92 77 49 79
NEXIUM 89 70 50 28
CARBIDOPA-LEVODOPA 88 87 51 88
RANITIDINE HCL 87 59 52 44
ZOLPIDEM TARTRATE 87 73 52 23
FAMOTIDINE 86 70 54 55
FENOFIBRATE 86 66 54 66
AMOX TR-POTASSIUM CLAVULANATE 85 63 56 128
DIVALPROEX SODIUM 85 65 56 72
PROPRANOLOL HCL 80 32 58 129
CYCLOBENZAPRINE HCL 77 38 R 59 63
MORPHINE SULFATE ER 75 51 S2 60 107
PLAVIX 74 55 61 51
CLINDAMYCIN HCL 73 56 62 345
BUSPIRONE HCL 73 55 62 124
ACARBOSE 72 70 64 347
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 42 64 33
PREDNISONE 71 55 66 36
CLONIDINE HCL 70 66 67 60
KLOR-CON M20 70 60 67 48
NOVOLOG 69 61 69 81
JANUVIA 69 51 69 73
VERAPAMIL ER 69 63 69 119
PANTOPRAZOLE SODIUM 69 67 69 30
CLOPIDOGREL 69 52 69 29
LACTULOSE 67 44 74 169
KLOR-CON 10 66 48 75 102
PAROXETINE HCL 66 63 75 69
PROMETHAZINE HCL 65 41 R 77 97
FELODIPINE ER 64 64 78 221
PROAIR HFA 64 33 78 56
TRAZODONE HCL 62 31 80 39
CEFTRIAXONE 59 59 81 227
ROPINIROLE HCL 57 51 82 74
OLANZAPINE 55 53 83 108
FLUTICASONE PROPIONATE 55 44 83 46
IPRATROPIUM-ALBUTEROL 54 52 85 110
SPIRONOLACTONE 53 47 86 57
TIZANIDINE HCL 53 0 86 133
NITROFURANTOIN MONO-MACRO 53 52 86 174
INSULIN SYRINGE 52 41 89 82
BACLOFEN 51 30 90 125
AMOXICILLIN 51 48 90 116
CARBAMAZEPINE 50 12 92 208
ALBUTEROL SULFATE 50 45 92 136
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.